NCT03676140View on ClinicalTrials.gov

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

PHASE3CompletedINTERVENTIONAL
Enrollment

20,000

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 15, 2018

Study Completion Date

January 1, 2019

Conditions
TrachomaYawsLymphatic FilariasesScabiesStrongyloidiasis
Interventions
DRUG

Albendazole on Day 1

Albendazole 400 mg oral tablet Single Dose Treatment on D1

DRUG

Ivermectin on Day 1

Ivermectin 200 µg/kg oral tablet Single Dose Treatment on Day 1

DRUG

Diethylcarbamazine on day 1

Diethylcarbamazine 6 mg/kg oral tablet Single Dose Treatment on Day 1

DRUG

Azithromycin on Day 1

Azithromycin 30mg/Kg oral tablet Single Dose Treatment On Day 1

DRUG

Azithromycin on Day 8

Azithromycin 30mg/Kg oral tablet Single Dose Treatment On Day 8

Trial Locations (1)

Unknown

Namatanai Hospital, Namatanai

Sponsors
All Listed Sponsors
collaborator

London School of Hygiene and Tropical Medicine

OTHER

lead

Lihir Medical Centre

OTHER